How do sponsors and CROs select clinical trial sites?
The sponsor is responsible for selecting investigators and institutions, and each investigator must be qualified by education, training and experience and show adequate resources and facilities to run the trial properly (ICH E6(R3) 3.7.1).
In practice sponsors and CROs check this through a feasibility questionnaire and a site qualification visit, confirming that the investigator and the staff involved have the qualifications, resources, facilities and equipment the protocol needs (ICH E6(R3) 3.11.4.5.2(a)).
What sponsors look at
- The investigator's qualifications and experience with the indication and the trial type (ICH E6(R3) 3.7.1).
- Enough time, qualified staff and facilities for the whole trial (ICH E6(R3) 2.2.2).
- Equipment, laboratories, pharmacy and storage for the investigational product.
- The site's track record with past trials: start-up speed, data quality, deviations and inspection history.
- Staff training and readiness for the protocol's critical tasks: consent, eligibility, safety reporting and product handling.
- The patient population the site serves. CRLN does no work on this part.
Why staff readiness is the hard part to see
A CV and a GCP certificate show that a person sat a course. They do not show whether the coordinator on a delegation log will make the right call on a consent or a safety report on a busy Saturday. Sponsors find that out at the first monitoring visit, which is late.
The Study Start Readiness Check gives a sponsor or CRO a readiness record for the staff named on a study: practice on realistic trial decisions scored against ICH E6(R3) and mapped to CRLN-TRG-001, our own standard, built on ICH E6(R3). The record shows group results and never individual names.
What a site can do before the feasibility call
- Keep every staff member's GCP training and expiry dates current in one place.
- Know who on the team is ready to be delegated which task.
- Have a readiness record a sponsor can open with one link. The free Site Portal does all three, and sites never pay.
Questions people also ask
Who is responsible for selecting the investigator?
The sponsor (ICH E6(R3) 3.7.1). For US drug studies the sponsor may select only investigators qualified by training and experience (21 CFR 312.53).
What is a site qualification visit?
A visit, on site or remote, where the sponsor or CRO confirms the investigator and staff have the qualifications, resources and facilities to run the trial (ICH E6(R3) 3.11.4.5.2(a)).
What does the sponsor give the site before selection?
The protocol and an up-to-date Investigator's Brochure, with enough time to review them (ICH E6(R3) 3.7.2).
Can a new site with no trial history be selected?
Yes, when the investigator is qualified and the site shows the resources the trial needs. Evidence that the staff are trained and ready for the protocol's tasks helps a new site most.
Primary sources
- ICH E6(R3) Guideline for Good Clinical Practice, final version adopted 6 January 2025 (ICH): https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf
- 21 CFR 312.53: Selecting investigators and monitors (eCFR): https://www.ecfr.gov/current/title-21/section-312.53
Last reviewed
2026-11-12